Droneshield Limited

DRO

DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Company’s products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Company’s capabilities include C-UAS, C-UxS Training, and Electronic Warfare.

ResMed Inc.

RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

Accent Group Limited

AX1

Accent Group Ltd. operates as an investment holding company, which engages in the retail of performance and lifestyle footwear. The company is headquartered in Richmond, Victoria. The company went IPO on 2004-07-07. The firm operates approximately 903 stores across 18 different retail banners, and distribution rights for 12 international brands across Australia and New Zealand. The firm operates through two segments: Retail and Wholesale. The Retail segment is engaged in selling of footwear and apparel directly to consumers. The Wholesale segment is engaged in selling of footwear and apparel in bulk internally and to other businesses. The Company’s banners and brands include Platypus Shoes, The Athlete’s Foot (TAF), Hype DC, Skechers, Merrell, Vans, Dr. Martens, Saucony, Timberland, HOKA, Superga, Subtype, Stylerunner, Glue Store, Nude Lucy and UGG.

Paradigm Biopharmaceuticals Limited.

PAR

Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-19. The firm is engaged in discovering, developing, and delivering pharmaceutical therapies. The company is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). The company develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).

WiseTech Global Limited

WTC

Wisetech Global Ltd. engages in the provision of software to the logistics services industry. The company is headquartered in Alexandria, New South Wales and currently employs 3,600 full-time employees. The company went IPO on 2016-04-11. The firm develops, sells, and implements software solutions which enable logistics service providers to facilitate the storage of goods and information, domestically and internationally. The company provides its solutions to approximately 17,000 customers in over 174 countries. The firm's technology, CargoWise, is an integrated, global software platform for logistics service providers. Its software enables logistics service providers to execute logistics transactions and manage their operations on one global database across multiple users, functions, offices, corporations, currencies, countries, and languages. Its main data centers in Australia, Europe and the United States deliver its CargoWise platform principally through the cloud, which customers access as needed and pay for usage as they execute on its platform.